Funding for this research was provided by:
National Institute of Mental Health (ZIAMH002793 and ZIAMH002852)
Received: 12 December 2019
Accepted: 2 March 2020
First Online: 14 March 2020
Ethics approval and consent to participate
: The National Institutes of Health Combined Neurosciences Institutional Review Board approved this study (Protocol 16-M-0105) and informed consent was obtained from all participants.
: Not applicable
: Sergey Shcherbinin, J. Craig Ruble, Nancy Kant, Emily C. Collins, and Hugh N. Nuthall were employees of Eli Lilly and Co. at the time the study was conducted. All other authors declare that they have no competing interests.